Clinical Trials Directory

Trials / Completed

CompletedNCT03085576

NATional TUnisian REgistry of Atrial Fibrillation

National Tunisian Registry of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
910 (actual)
Sponsor
Dacima Consulting · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

A non-interventional, national longitudinal study of atrial fibrillation performed with 91 cardiologists.

Detailed description

The NATURE-AF study is carried out in Tunisia at cardiology consultations in hospitals and in the liberal sector. A total of 91 cardiologists participate in the selection of patients as investigators. The study is a longitudinal non-interventional registry of atrial fibrillation. The data collected are managed by the DACIMA Clinical Suite® platform, which complies with international standards: FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPPA (Health Insurance Portability and Accountability Act), ICH (International Conference on Harmonisation), MedDRA (Medical Dictionary for Regulatory Activities). The DACIMA Clinical Suite® platform allows to track the data entered, check for inconsistencies and missing data, and schedule monitoring visits. A Steering Committee is set up to monitor patient inclusions, verify data sources, perform audit trails and prepare the statistical analysis plan for the study.

Conditions

Timeline

Start date
2017-03-01
Primary completion
2018-05-30
Completion
2018-07-30
First posted
2017-03-21
Last updated
2021-04-29

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT03085576. Inclusion in this directory is not an endorsement.